Decoy Therapeutics Inc. (DCOY)
NASDAQ: DCOY · Real-Time Price · USD
5.48
-0.04 (-0.64%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Decoy Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 10.71 | 2.43 | 5.9 | 12.11 | 29.21 | Upgrade
|
| Cash & Short-Term Investments | 10.71 | 2.43 | 5.9 | 12.11 | 29.21 | Upgrade
|
| Cash Growth | 339.92% | -58.74% | -51.27% | -58.56% | 162.75% | Upgrade
|
| Receivables | - | - | - | 1.61 | - | Upgrade
|
| Prepaid Expenses | 0.28 | 0.33 | 0.62 | 0.8 | 0.95 | Upgrade
|
| Other Current Assets | - | 0.22 | - | - | - | Upgrade
|
| Total Current Assets | 10.99 | 2.99 | 6.52 | 14.52 | 30.16 | Upgrade
|
| Property, Plant & Equipment | 0.04 | - | - | - | - | Upgrade
|
| Goodwill | - | - | - | - | 8.87 | Upgrade
|
| Long-Term Accounts Receivable | - | - | - | - | 1.61 | Upgrade
|
| Other Long-Term Assets | 0.03 | 0.04 | 0.07 | 0.13 | 0.19 | Upgrade
|
| Total Assets | 11.06 | 3.02 | 6.59 | 14.65 | 40.83 | Upgrade
|
| Accounts Payable | 0.94 | 0.94 | 0.6 | 2.86 | 1.54 | Upgrade
|
| Accrued Expenses | 0.86 | 0.35 | 0.41 | 1.41 | 0.57 | Upgrade
|
| Short-Term Debt | - | 0.22 | 0.29 | - | - | Upgrade
|
| Current Unearned Revenue | 3.23 | - | - | - | - | Upgrade
|
| Other Current Liabilities | 0.14 | - | - | - | - | Upgrade
|
| Total Current Liabilities | 5.17 | 1.51 | 1.3 | 4.27 | 2.11 | Upgrade
|
| Total Liabilities | 5.17 | 1.51 | 1.3 | 4.27 | 2.11 | Upgrade
|
| Common Stock | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 100.33 | 83.44 | 81.64 | 74.19 | 70.92 | Upgrade
|
| Retained Earnings | -94.44 | -81.92 | -76.35 | -63.81 | -32.2 | Upgrade
|
| Total Common Equity | 5.89 | 1.51 | 5.29 | 10.38 | 38.72 | Upgrade
|
| Shareholders' Equity | 5.89 | 1.51 | 5.29 | 10.38 | 38.72 | Upgrade
|
| Total Liabilities & Equity | 11.06 | 3.02 | 6.59 | 14.65 | 40.83 | Upgrade
|
| Total Debt | - | 0.22 | 0.29 | - | - | Upgrade
|
| Net Cash (Debt) | 10.71 | 2.21 | 5.61 | 12.11 | 29.21 | Upgrade
|
| Net Cash Growth | 384.03% | -60.56% | -53.66% | -58.56% | 174.53% | Upgrade
|
| Net Cash Per Share | 110.45 | 27.59 | - | - | - | Upgrade
|
| Filing Date Shares Outstanding | 0.53 | - | - | - | 0 | Upgrade
|
| Total Common Shares Outstanding | 0.53 | - | - | - | 0 | Upgrade
|
| Working Capital | 5.82 | 1.48 | 5.22 | 10.25 | 28.05 | Upgrade
|
| Book Value Per Share | 11.07 | - | - | - | 30805.88 | Upgrade
|
| Tangible Book Value | 5.89 | 1.51 | 5.29 | 10.38 | 29.86 | Upgrade
|
| Tangible Book Value Per Share | 11.07 | - | - | - | 23752.65 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.